At the time of writing, Repligen Corp [RGEN] stock is trading at $162.51, up 5.28%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RGEN shares have gain 6.65% over the last week, with a monthly amount drifted -1.63%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on October 01, 2025, when HSBC Securities initiated its Buy rating and assigned the stock a price target of $150. Previously, Evercore ISI upgraded its rating to Outperform on September 22, 2025, and kept the price target unchanged to $155. Barclays started tracking the stock assigning an Overweight rating and suggested a price target of $150 on June 24, 2025. Wolfe Research upgraded its rating to an Outperform but $160 remained the price target by the analyst firm on April 29, 2025. Evercore ISI started tracking with a In-line rating for this stock on March 18, 2025, and assigned it a price target of $155. In a note dated February 10, 2025, TD Cowen initiated a Buy rating and provided a target price of $200 on this stock.
For the past year, the stock price of Repligen Corp fluctuated between $102.96 and $182.52. Currently, Wall Street analysts expect the stock to reach $171 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $162.51 at the most recent close of the market. An investor can expect a potential return of 5.22% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
According to Repligen Corp [NASDAQ:RGEN], the company’s sales were 707.89M for trailing twelve months, which represents an 21.91% jump. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 157.35 points at the first support level, and at 152.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 166.03, and for the 2nd resistance point, it is at 169.55.
Ratios To Look Out For
It is important to note that Repligen Corp [NASDAQ:RGEN] has a current ratio of 8.36. In addition, the Quick Ratio stands at 7.14 and the Cash Ratio stands at 5.71. Considering the valuation of this stock, the price to sales ratio is 12.92, the price to book ratio is 4.39 and price to earnings (TTM) ratio is 6323.35.
Transactions by insiders
Recent insider trading involved Bylund James, Chief Operating Officer, that happened on Nov 18 ’25 when 2191.0 shares were sold. Officer, Bylund James completed a deal on Nov 18 ’25 to buy 2191.0 shares. Meanwhile, Director Hunt Anthony sold 20000.0 shares on Nov 13 ’25.
